topimax filmuhúðuð tafla 100 mg
janssen-cilag ab - topiramatum inn - filmuhúðuð tafla - 100 mg
topimax filmuhúðuð tafla 200 mg
janssen-cilag ab - topiramatum inn - filmuhúðuð tafla - 200 mg
topimax filmuhúðuð tafla 25 mg
janssen-cilag ab - topiramatum inn - filmuhúðuð tafla - 25 mg
topimax filmuhúðuð tafla 50 mg
janssen-cilag ab - topiramatum inn - filmuhúðuð tafla - 50 mg
topimax hart hylki 15 mg
janssen-cilag ab - topiramatum inn - hart hylki - 15 mg
topiramat actavis filmuhúðuð tafla 100 mg
actavis group ptc ehf. - topiramatum inn - filmuhúðuð tafla - 100 mg
topiramat actavis filmuhúðuð tafla 25 mg
actavis group ptc ehf. - topiramatum inn - filmuhúðuð tafla - 25 mg
topiramat actavis filmuhúðuð tafla 50 mg
actavis group ptc ehf. - topiramatum inn - filmuhúðuð tafla - 50 mg
pombiliti
amicus therapeutics europe limited - cipaglucosidase alfa - glycogen geymsluskammt tegund ii - Önnur meltingarvegi og efnaskipti vörur, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).
opfolda
amicus therapeutics europe limited - miglustat - glycogen geymsluskammt tegund ii - Önnur meltingarfæri og umbrotsefni - opfolda (miglustat) is an enzyme stabiliser of cipaglucosidase alfa long-term enzyme replacement therapy in adults with late-onset pompe disease (acid α- glucosidase [gaa] deficiency).